255 related articles for article (PubMed ID: 23126660)
1. Th2 cytokine antagonists: potential treatments for severe asthma.
Hansbro PM; Scott GV; Essilfie AT; Kim RY; Starkey MR; Nguyen DH; Allen PD; Kaiko GE; Yang M; Horvat JC; Foster PS
Expert Opin Investig Drugs; 2013 Jan; 22(1):49-69. PubMed ID: 23126660
[TBL] [Abstract][Full Text] [Related]
2. Effects of histamine on Th1/Th2 cytokine balance.
Packard KA; Khan MM
Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
[TBL] [Abstract][Full Text] [Related]
3. Targeting T cells for asthma.
Heijink IH; Van Oosterhout AJ
Curr Opin Pharmacol; 2005 Jun; 5(3):227-31. PubMed ID: 15907907
[TBL] [Abstract][Full Text] [Related]
4. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
Chung KF
J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
[TBL] [Abstract][Full Text] [Related]
5. Targeting the interleukin pathway in the treatment of asthma.
Chung KF
Lancet; 2015 Sep; 386(9998):1086-96. PubMed ID: 26383000
[TBL] [Abstract][Full Text] [Related]
6. Targeting memory Th2 cells for the treatment of allergic asthma.
Epstein MM
Pharmacol Ther; 2006 Jan; 109(1-2):107-36. PubMed ID: 16081161
[TBL] [Abstract][Full Text] [Related]
7. New therapies for asthma: is there any progress?
Barnes PJ
Trends Pharmacol Sci; 2010 Jul; 31(7):335-43. PubMed ID: 20554041
[TBL] [Abstract][Full Text] [Related]
8. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
Moss RB
Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
[TBL] [Abstract][Full Text] [Related]
9. Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?
Chung KF
Curr Opin Investig Drugs; 2003 Nov; 4(11):1320-6. PubMed ID: 14758771
[TBL] [Abstract][Full Text] [Related]
10. Characterization of asthma endotypes: implications for therapy.
Stokes JR; Casale TB
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):121-5. PubMed ID: 27499539
[TBL] [Abstract][Full Text] [Related]
11. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
Mitchell J; Dimov V; Townley RG
Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
[TBL] [Abstract][Full Text] [Related]
12. Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.
Levine SJ; Wenzel SE
Ann Intern Med; 2010 Feb; 152(4):232-7. PubMed ID: 20157138
[TBL] [Abstract][Full Text] [Related]
13. New drugs for asthma.
Barnes PJ
Nat Rev Drug Discov; 2004 Oct; 3(10):831-44. PubMed ID: 15459674
[TBL] [Abstract][Full Text] [Related]
14. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
Fonseca DE; Kline JN
Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
[TBL] [Abstract][Full Text] [Related]
15. Novel and emerging therapies for asthma.
Leath TM; Singla M; Peters SP
Drug Discov Today; 2005 Dec; 10(23-24):1647-55. PubMed ID: 16376825
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-directed therapy in asthma.
Ichinose M; Barnes PJ
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):263-9. PubMed ID: 15379594
[TBL] [Abstract][Full Text] [Related]
17. Cortex Mori Radicis extract exerts antiasthmatic effects via enhancement of CD4(+)CD25(+)Foxp3(+) regulatory T cells and inhibition of Th2 cytokines in a mouse asthma model.
Kim HJ; Lee HJ; Jeong SJ; Lee HJ; Kim SH; Park EJ
J Ethnopharmacol; 2011 Oct; 138(1):40-6. PubMed ID: 21875661
[TBL] [Abstract][Full Text] [Related]
18. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
Maeda S; Yanagihara Y
Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
[TBL] [Abstract][Full Text] [Related]
19. Cytokines or their antagonists for the treatment of asthma.
O'Byrne PM
Chest; 2006 Jul; 130(1):244-50. PubMed ID: 16840409
[TBL] [Abstract][Full Text] [Related]
20. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
